Podcast Rankings
✕
All
Arts
Books
Design
Fashion & Beauty
Food
Performing Arts
Visual Arts
Business
Careers
Entrepreneurship
Investing
Management
Marketing
Non-Profit
Comedy
Comedy Interviews
Improv
Stand-Up
Education
Courses
How To
Language Learning
Self-Improvement
Fiction
Comedy Fiction
Drama
Science Fiction
Government
Health & Fitness
Alternative Health
Fitness
Medicine
Mental Health
Nutrition
Sexuality
History
Kids & Family
Education for Kids
Parenting
Pets & Animals
Stories for Kids
Leisure
Animation & Manga
Automotive
Aviation
Crafts
Games
Hobbies
Home & Garden
Video Games
Music
Music Commentary
Music History
Music Interviews
News
Business News
Daily News
Entertainment News
News Commentary
Politics
Sports News
Tech News
Religion & Spirituality
Buddhism
Christianity
Hinduism
Islam
Judaism
Religion
Spirituality
Science
Astronomy
Chemistry
Earth Sciences
Life Sciences
Mathematics
Natural Sciences
Nature
Physics
Social Sciences
Society & Culture
Documentary
Personal Journals
Philosophy
Places & Travel
Relationships
Sports
Baseball
Basketball
Cricket
Fantasy Sports
Football
Golf
Hockey
Rugby
Running
Soccer
Swimming
Tennis
Volleyball
Wilderness
Wrestling
TV & Film
After Shows
Film History
Film Interviews
Film Reviews
TV Reviews
Technology
True Crime
Podcast
Music
Movie
Game
Book
🎧Podcast
🎧The Uromigos
Episode 298: ASCO GU 2024 Highlights
Episode 298: ASCO GU 2024 Highlights
Release Date:
2024-02-01 08:05:47
Silke, Tom and Brian cover the bases.
Episode 298: ASCO GU 2024 Highlights
Reddit
はてなブックマーク
вконтакте
百度
Title
Episode 298: ASCO GU 2024 Highlights
Copyright
The Uromigos
Release Date
2024-02-01 08:05:47
flashback
2024-06-10
Episode 330: ASCO 2024 Highlights
2024-06-08
Episode 329: Japan in the Uromigos Cup qualifying round
2024-06-05
Episode 328 ASCO24: Emergency podcast - what the NADINA trial means for preoperative GU cancer studies
2024-06-04
Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates
2024-06-04
Episode 326 ASCO24: KIM-1 in Renal Cancer
2024-06-03
Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer
2024-06-03
Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC
2024-06-03
Episode 323 ASCO24: TDXD in Bladder Cancer
2024-06-02
Episode 322 ASCO24: The role of ctDNA in the TheraP trial (LuPSMA vs cabazitaxel in CRPC)
2024-06-02
Episode 321 ASCO24: CHAARTED-2 in prostate cancer - is the sequel as good as the original?
2024-05-25
Episode 320: Team Canada's entry for the Uromigos Cup
2024-05-20
Episode 319: ASCO 2024: A Preview of GU Data
2024-05-14
Episode 318: The Lancet Commission on prostate cancer: planning for a surge in cases
2024-05-02
Episode 317: AUA 2024 Preview with the AUA Secretary
2024-04-29
Episode 316: APCCC 2024 Summary with Silke Gillessen
2024-04-27
Episode 315: APCCC 2024 Quickfire - Bone health, hot flashes and gynecomastia in prostate cancer
2024-04-27
Episode 314: APCCC 2024 Cardiovascular risks with hormone therapy in prostate cancer
2024-04-27
Episode 313: APCCC 2024 Debate - Radiation therapy in advanced disease
2024-04-27
Episode 312: APCCC 2024 Radiation therapy after surgery for prostate cancer
2024-04-24
Episode 311: The Uromigos Paper of the Month - The POUT Trial
2024-04-18
Episode 310: Dosing and duration of drugs from a cost perspective
2024-04-08
Episode 309: EAU24 Checkmate 274 - OS for adjuvant nivolumab in bladder cancer
2024-04-08
Episode 308: EAU24 IMVIGOR 011 - Outcome of ctDNA negative patients post-cystectomy
2024-04-03
Episode 307: Bladder-Sparing Approaches Part 2
2024-03-29
Episode 306: The Uromigos Paper of the Month - Chemo/Nivo as a bladder sparing approach in UC
2024-03-20
Episode 305: FDA and Oncology Clinical Trials
2024-03-12
Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC
2024-03-06
Episode 303: Community GU Oncology
2024-02-26
Episode 302: Part 2- Adjuvant Therapy in solid tumors
2024-02-21
Episode 301: Cancer research from a global perspective.
2024-02-12
Episode 300: Adjuvant PD1 Therapy in Solid Tumours
2024-02-07
Episode 299: Androgen receptor ligand-directed degrader BMS-986365
2024-02-01
Episode 298: ASCO GU 2024 Highlights
2024-01-30
Episode 297: ASCO GU 2024: CONTACT2 Part 2 - The Aftermath
2024-01-28
Episode 296: ASCO GU 2024: Novel approaches to QOL and belzutifan
2024-01-28
Episode 295: ASCO GU 2024: Adjuvant Therapy in Renal Cancer
2024-01-27
Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer
2024-01-27
Episode 293: ASCO GU 2024: BRCAaway and CONTACT2
2024-01-26
Episode 292: ASCO GU 2024: HPN328 - A Tri-Specific T Cell Engager in Prostate Cancer
2024-01-26
Episode 291: ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer
2024-01-17
Episode 290: ASCO GU 2024 Preview
2024-01-16
Episode 289: The Uromigos Paper of the Month - TALAPRO2 in Nature Medicine
2024-01-10
Episode 288: APCCC #3: Controversies around Radiotherapy
2024-01-05
Episode 287 APCCC: Early Discontinuation of Therapy in HSPC
2024-01-03
Episode 286: APCCC Prostate Cancer Meeting Overview
2023-12-22
Episode 285: Holiday Special: Renal Cancer in 2023
2023-12-21
Episode 284: Tres amigas: Lo más destacado del cáncer en urología en 2023
2023-12-20
Episode 283: Holiday Special: Prostate Cancer in 2023
2023-12-14
Episode 282: Holiday Special: Bladder Cancer in 2023
2023-12-08
Episode 281: The Uromigos Paper of the Month - Lu-177 with Pembrolizumab in Prostate Cancer
2023-11-17
Episode 280: IKCS 2023 Overview
2023-11-14
An apology
2023-11-07
Episode 279: Management of IO-resistant RCC at #UromigosLive 2023
2023-11-05
Episode 278: Current and Future Status of Radioligand Therapy at #UromigosLive 2023
2023-11-04
Episode 277: NMIBC Discussion at #UromigosLive 2023
2023-10-29
Episode 276: ESMO 2023 Highlights
2023-10-28
Episode 275: Live meeting preview for #UromigosLive 2023 in Nashville
2023-10-28
Episode 274: ESMO 2023 STEAP1/BiTE in CRPC shows promise
2023-10-27
Episode 273: ESMO 2023 - Toripalimab and axitinib in clear cell RCC
2023-10-23
Episode 272: ESMO 2023 - EV302 and CM901 in 1st line bladder cancer
2023-10-23
Episode 271: ESMO 2023 - THOR: Erdafitinib in bladder cancer
2023-10-21
Episode 270: ESMO 2023 - Belzutifan in renal cancer
2023-10-21
Episode 269: ESMO 2023 - antibody drug conjugate doublets in UC
2023-10-21
Episode 268: ESMO 2023 - Enzalutamide and 177Lu-PSMA-617 in CRPC with Louise Emmett
2023-10-12
Episode 267: ESMO preview - things to look out for at the meeting
2023-10-10
Episode 266: Radiotherapy for prostate cancer
2023-10-03
Episode 265: Brachytherapy with Jeff Michalski
2023-09-27
Episode 264: Prostatectomy vs RT vs surveillance- the PROTECT trial
2023-09-21
Episode 263: Toni Choueiri and papillary renal cancer
2023-09-13
Episode 262: Paper of the month abiraterone +/- cabazitaxel in CRPC.
2023-09-04
Episode 261: part 2 ctDNA in bladder cancer
2023-08-30
Episode 260: Celeste Simon: how to make a career in translation science work.
2023-08-24
Episode 259: Cystectomy for bladder cancer
2023-08-16
Episode 258: Curative radiotherapy for bladder cancer: Golden Ticket Winner #1
2023-08-07
Episode 257: Chana Weinstock from the FDA
2023-07-28
Episode 256: ctDNA in urothelial studies.
2023-07-26
Episode 255: How to get an academic paper accepted
2023-07-18
Episode 254: New RCC studies at KCRS 2023 with Laurence Albiges
2023-07-13
Episode 253: Patients' perspectives on adjuvant and 1st line RCC
2023-07-05
Episode 252: Talazoparib and its FDA approval in CRPC
2023-06-27
Episode 251: Final part of VEGF/TKI vs IPI/NIVO discussion
2023-06-19
Episode 250: Bob Motzer discusses IPI/Nivo vs VEGF/PD1
2023-06-19
Episode 249: ASCO 2023 emergency podcast IPI/NIVO vs VEGF/PD1 in kidney cancer
2023-06-14
Episode 248: ASCO23 GU highlights
2023-06-06
Episode 246: ASCO 2023: EV pembro and erdafitinib +/- cetrelimab in 1st line UC
2023-06-06
Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer
2023-06-06
Episode 244: ASCO 2023 PEACE-1 in CRPC
2023-06-06
Episode 243: ASCO 2023 TALAPRO-2: Phase 3 Study of Talazoparib + Enzalutamide
2023-06-05
Episode 242: ASCO 2023 THOR study - erdafitinib vs chemo in bladder cancer
2023-06-01
Episode 241: Statistics for clinical trials
2023-05-31
Episode 240: Preview of GU Cancer at ASCO 2023
2023-05-23
Episode 239: The STAMPEDE trial
2023-05-15
Episode 238: Paper of the month: Biomarkers for neoadjuvant PD(L)1 therapy
2023-05-09
Episode 237: 2023 AUA Highlights
2023-05-02
Episode 236: ODAC for olaparib
2023-04-24
Episode 235: Danny Heng and the IMDC classification in renal cancer
2023-04-20
Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer
2023-04-16
Episode 233: Destaques da 14ª reunião internacional brasileira de câncer urológico
2023-04-14
Episode 232: Belzutifan in early and late renal cancer
2023-04-05
Episode 231: Ursula Vogl, MD in the Rising Star Series